CytomX Therapeutics Inc. (CTMX)
Market Closed
27 Jul, 20:00
$
3. 25
+0.01
+0.3086%
$
566.1M Market Cap
- P/E Ratio
- Div Yield
2.46M Volume
-0.06 Eps
$ 3.24
Previous Close Investors:
Want to track CTMX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CytomX Therapeutics Inc. (CTMX) Statistics
Valuation metrics
Market Cap 566.1M
Enterprise value 495.1M
Trailing P/E (ttm) -8.97
Forward P/E -10.06
PEG ratio 0.05
Price/Sales (ttm) 14.66
Price/Book (mrq) 1.8
Enterprise Value/Revenue 13.93
Enterprise Value/EBITDA -8.59
Overview
Shares outstanding 170.19M
Float 139.4M
Shares short 22.03M
% Held by insiders 0.01%
% Held by institutions 0.76%
Average volume (10 days) 3.8M
Average volume (90 days) 4.38M
Price summary
52-Week low 1.72
52-Week high 8.21
Beta 2.48
50-Day moving average 3.33
200-Day moving average 4.62
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.66%
Operating margin -1.82%
Operational effectiveness
Return on assets -0.16%
Return on equity -0.37%
Income Statement
Revenue (ttm) 76.2M
Revenue per share (ttm) 0.2
Quarterly revenue growth (yoy) -0.98%
Gross profit (ttm) 76.2M
EBITDA -18.19M
Net income to common (ttm) -20.37M
Diluted EPS (ttm) -0.33
Quarterly earnings growth (yoy) -0.98%
Balance Sheet
Total cash (mrq) 137.05M
Total cash per share (mrq) 1.96
Total debt (mrq) 4.24M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 10.38%
Book value per share (mrq) 1.8
Cash Flow
Cash flow statement -75.59M
Levered free cash flow (LFCF) -43.21M
